VINC Insider Trading

Insider Ownership Percentage: 15.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Vincerx Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Vincerx Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100k-$50k$0$50k$100kTotal Insider BuyingTotal Insider Selling

Vincerx Pharma Share Price & Price History

Current Price: $0.66
Price Change: Price Increase of +0.0298 (4.73%)
As of 04/3/2025 05:00 PM ET

This chart shows the closing price history over time for VINC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.66Closing price on 04/03/25:

SEC Filings (Institutional Ownership Changes) for Vincerx Pharma (NASDAQ:VINC)

44.02% of Vincerx Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VINC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$6.12ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal InflowsTotal Outflows
Vincerx Pharma logo
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.
Read More on Vincerx Pharma

Today's Range

Now: $0.66
Low: $0.62
High: $0.69

50 Day Range

MA: $1.06
Low: $0.53
High: $2.08

52 Week Range

Now: $0.66
Low: $0.48
High: $136.80

Volume

424,375 shs

Average Volume

344,190 shs

Market Capitalization

$1.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43

Who are the company insiders with the largest holdings of Vincerx Pharma?

Vincerx Pharma's top insider investors include:
  1. Ahmed Md Hamdy (Insider)
  2. Alexander A Seelenberger (Insider)
Learn More about top insider investors at Vincerx Pharma.